POSSIBILITIES OF USING PROBIOTICS FOR HELICOBACTER PYLORI ERADICATION: MAASTRICHT V CONSENSUS CONFERENCE RECOMMENDATIONS
The new European consensus for the management of patients with Helicobacter pylori (Hp)-associated diseases draws attention to the fact that the stomach has a large number of microorganisms that can influence the development of abnormalities. The use of probiotics contributes to a reduction in the incidence of side effects and enhances the effectiveness of Hp eradication.